Provided by Tiger Trade Technology Pte. Ltd.

GENSCRIPT BIO

31.800
-0.200-0.62%
Volume:30.79M
Turnover:998.56M
Market Cap:69.99B
PE:-16.50
High:33.760
Open:30.880
Low:30.800
Close:32.000
52wk High:37.360
52wk Low:10.360
Shares:2.20B
HK Float Shares:2.20B
Volume Ratio:1.56
T/O Rate:1.40%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-1.927
ROE:-15.33%
ROA:1.54%
PB:2.30
PE(LYR):-16.50
PS:10.56

Loading ...

Genscript Associate Reports $657 Million in Carvykti Sales Under License Agreement

MT Newswires Live
·
Jul 16

Movement Alert|GenScript Biotech Falls 6.34% in Regular Trading, CARVYKTI Q2 Sales Growth Deceleration Triggers Profit-Taking

Market Focus
·
Jul 16

Genscript Biotech: Associate Legend Biotech Posts US$657.00 Million Q2 Sales for CARVYKTI®

Bulletin Express
·
Jul 15

GENSCRIPT BIO Reports Q2 Net Trade Sales of CARVYKTI® at Approximately $657 Million

Stock News
·
Jul 15

Movement Alert|Genscript Biotech Rises 5.04% in Regular Trading, CXO Sector Interim Results Beat Expectations Driving Sector Momentum

Market Focus
·
Jul 15

Movement Alert|Genscript Biotech Rises 5.27% in Regular Trading, CXO Sector Mid-Year Earnings Window Continues to Catalyze

Market Focus
·
Jul 13

Movement Alert|Genscript Biotech Rises 5.38% in Regular Trading, CXO Sector Rallies as Mid-Year Earnings Window Opens with Policy Tailwinds

Market Focus
·
Jul 10

Movement Alert|GenScript Biotech Rises 5.07% in Regular Trading, AI Drug Discovery Theme Drives Sector-Wide Rally

Market Focus
·
Jul 06

Movement Alert|Genscript Biotech Rises 6.46% in Regular Trading, Trading at HK$13.14

Market Focus
·
Jul 02

Hong Kong Market Midday Update: Hang Seng Index Edges Up, Chip Stocks Lead Gains

Stock News
·
Jun 24

CRO Sector Stocks Show Robust Gains in Early Trading Session

Deep News
·
Jun 24

Contract Research Organization Stocks Surge as BIO Conference Highlights Chinese CXO Global Competitiveness; Pharmaceutical Sector Openness Achieves New Milestone

Stock News
·
Jun 24

Movement Alert|GenScript Biotech Rises 5.34% in Regular Trading, Technical Recovery After Legend Biotech-Driven Selloff

Market Focus
·
Jun 24

Movement Alert|GenScript Biotech Falls 8.14% in Regular Trading, Associate Legend Biotech US Stock Plunge Drags Share Price

Market Focus
·
Jun 22

BUZZ-Legend Biotech slides on $226 mln share sale

Reuters
·
Jun 18

Movement Alert|GenScript Biotech Rises 5.41% in Regular Trading, Recovering After Legend Biotech LB2501 Clinical Data Triggered Sell-the-News Pullback

Market Focus
·
Jun 18

Genscript Associate Reports Promising Phase 1 Data for LB2501 in B-Cell Lymphoma

MT Newswires Live
·
Jun 15

Genscript Biotech Share Price Plummets Despite Positive Trial Results from Associate Company

Stock News
·
Jun 15

Movement Alert|GenScript Biotech Falls 6.07% in Regular Trading, CXO Sector Sentiment Remains Fragile Amid US-China Biomedical Policy Uncertainty

Market Focus
·
Jun 15

GenScript Biotech: Associate Legend Achieves 100% ORR with First-in-Class Dual-Targeting CAR-T LB2501 in Early B-NHL Trial

Bulletin Express
·
Jun 14